Hypertension Trial, Recruiting (NCT04439370)

Hypertension Trial, Recruiting NCT04439370 Sponsor: University of Minnesota Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT04439370 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women aged 35–49 or 50–70 who went through menopause before age 40 (called premature menopause) or at age 45 or younger (called early menopause)
Women aged 35–49 who have not yet reached menopause (still having periods)
Women aged 50–70 who went through menopause at the typical age (after age 45)
Menopause must be confirmed by having had no periods for 12 months and a specific hormone level (FSH above 30 mIU/mL) shown in a blood test

Who may not be able to join:

People who have used nicotine or tobacco products in the past six months
People who have diabetes or asthma
People who have been diagnosed with a significant narrowing of the arteries in the neck (carotid stenosis)
People with a history of significant problems with the nervous system that controls automatic body functions, heart disease, breathing/lung disease, or a serious neurological condition such as a stroke or traumatic brain injury
People with existing problems related to metabolism or hormone-producing glands
People taking any heart or blood pressure medications that the trial team determines could interfere with the study results
Premenopausal participants currently taking the contraceptive pill or other hormone-based treatments that the trial team determines could interfere with study results
Women who experienced early or premature menopause and are not willing to stop taking the contraceptive pill or hormone replacement therapy for the duration of the study
People who are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 612-625-3175

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04439370

Sponsor: University of Minnesota

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: 612-625-3175

More information: https://clinicaltrials.gov/study/NCT04439370

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women aged 35–49 or 50–70 who went through menopause before age 40 (called premature menopause) or at age 45 or younger (called early menopause)
Women aged 35–49 who have not yet reached menopause (still having periods)
Women aged 50–70 who went through menopause at the typical age (after age 45)
Menopause must be confirmed by having had no periods for 12 months and a specific hormone level (FSH above 30 mIU/mL) shown in a blood test

Who may not be able to join:

People who have used nicotine or tobacco products in the past six months
People who have diabetes or asthma
People who have been diagnosed with a significant narrowing of the arteries in the neck (carotid stenosis)
People with a history of significant problems with the nervous system that controls automatic body functions, heart disease, breathing/lung disease, or a serious neurological condition such as a stroke or traumatic brain injury
People with existing problems related to metabolism or hormone-producing glands
People taking any heart or blood pressure medications that the trial team determines could interfere with the study results
Premenopausal participants currently taking the contraceptive pill or other hormone-based treatments that the trial team determines could interfere with study results
Women who experienced early or premature menopause and are not willing to stop taking the contraceptive pill or hormone replacement therapy for the duration of the study
People who are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Minnesota

Registry

ClinicalTrials.gov

Start date

1 October 2019

Est. completion

30 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Muscle Sympathetic Nerve Activity (MSNA) (bursts per minute); Muscle Sympathetic Nerve Activity (MSNA) (bursts/100 heart beats); Cardiac baroreflex sensitivity; Sympathetic baroreflex sensitivity; Systolic Blood Pressure (mmHg); Diastolic Blood Pressure (mmHg); Mean Arterial Blood Pressure (mmHg); Heart Rate (beats/min)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov